Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) in Elementary Schools

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03796754
Recruitment Status : Active, not recruiting
First Posted : January 8, 2019
Last Update Posted : February 2, 2021
Sponsor:
Information provided by (Responsible Party):
Andreas Michalsen, Charite University, Berlin, Germany

Brief Summary:
The aim of this study is a first evaluation of the effectiveness of the YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) to evaluate potential effects in stress reduction and concomitant psychological parameters.

Condition or disease Intervention/treatment Phase
Stress, Psychological Behavioral: YoBEKA Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 250 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Integration of the YoBEKA Program (Yoga, Movement, Relaxation, Concentration and Mindfulness) Into Elementary Schools in Germany
Actual Study Start Date : January 21, 2019
Actual Primary Completion Date : February 15, 2020
Estimated Study Completion Date : December 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stress

Arm Intervention/treatment
Active Comparator: YoBEKA Intervention Behavioral: YoBEKA
The teachers and students of the YoBEKA study arm receive a guided YoBEKA practice from an experienced YoBEKA trainer during the regular 4 month intervention period. The YoBEKA program is based on a combination of different, easy to perform exercises appropriate to the school situation, consisting of postures, verses for speech, song and movement, affirmations in movement to promote balance and coordination, and various rest and silence exercises to promote body awareness and relaxation techniques. The teaching is ideologically neutral and without religious background. The participating teachers receive an initial two-hour YoBEKA introductory course. Every 2 weeks there is a one to two-hour training course. The pedagogical specialists are supported once a week by an experienced YoBEKA trainer. The teachers are encouraged to integrate the learned exercises independently and regularly into their everyday school life.

No Intervention: Control group



Primary Outcome Measures :
  1. Questionnaire on the assessment of stress and stress management in childhood and adolescence - Revision (SSKJ 3-8 R) [ Time Frame: Change baseline, 4 months ]
    Filled out by students, assessing composite score (range 29-94): subscale 1 (stress-vulnerability [range 7-28]) summed with subscale 3 (stress symptoms and well-being [range 22-66]), lower score meaning a better outcome


Secondary Outcome Measures :
  1. Inventory of the quality of life of children and adolescents (KIDSCREEN-27 children) [ Time Frame: Change Baseline, 4 months, 12 months ]
    Filled out by students, assessing full scale, range 27-135, lower score meaning a better outcome

  2. Perceived Stress Scale (PSS) [ Time Frame: Change Baseline, 4 months, 12 months ]
    Filled out by teachers, assessing full scale, range 0-40, lower score meaning a better outcome

  3. Teacher anxiety and stress inventory (LASI) [ Time Frame: Change Baseline, 4 months, 12 months ]
    Filled out by teachers, assessing LASI 2, range 46-230, higher score meaning a better outcome

  4. Screening for somatoform disorders of childhood and adolescence (SOMS-E) [ Time Frame: Change Baseline, 4 months, 12 months ]
    Filled out by parents, assessing full scale, range 55-110, lower score meaning a better outcome

  5. Inventory of the quality of life of children and adolescents (KIDSCREEN-52 parents) [ Time Frame: Change Baseline, 4 months, 12 months ]
    Filled out by parents, assessing full scale, range 27-135, lower score meaning a better outcome


Other Outcome Measures:
  1. Heart rate variability [ Time Frame: Baseline, 4 months, 12 months ]
    Assessed with Faros 180 over 24 hours

  2. Qualitative interviews [ Time Frame: 4 months, 12 months ]
    Semi-structured interviews in focus groups



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Students from participating primary schools in Berlin aged 6-12 years
  • Written declaration of consent of the parent or legal guardian

Exclusion criteria:

  • Serious chronic or acute diseases
  • Immobility or serious restriction for gymnastic exercises due to orthopaedic, neurological or other medical causes
  • Participation in another study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03796754


Locations
Layout table for location information
Germany
Charite University
Berlin, Germany, 14109
Sponsors and Collaborators
Charite University, Berlin, Germany
Layout table for additonal information
Responsible Party: Andreas Michalsen, Principal Investigator, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT03796754    
Other Study ID Numbers: YoBEKA
First Posted: January 8, 2019    Key Record Dates
Last Update Posted: February 2, 2021
Last Verified: February 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Stress, Psychological
Behavioral Symptoms